Brief Report: Exploratory Analysis of Maintenance Therapy in Patients With Extensive-Stage SCLC Treated First Line With Atezolizumab Plus Carboplatin and Etoposide-Reference-Cited by-同舟云学术

Brief Report: Exploratory Analysis of Maintenance Therapy in Patients With Extensive-Stage SCLC Treated First Line With Atezolizumab Plus Carboplatin and Etoposide

Published:2022-09 Issue:9 Volume:17 Page:1122-1129
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Reck Martin,Mok Tony S.K.,Mansfield Aaron,De Boer Richard,Losonczy Gyorgy,Sugawara Shunichi,Dziadziuszko Rafal,Krzakowski Maciej,Smolin Alexey,Hochmair Maximilian,Garassino Marina Chiara,de Castro Junior Gilberto,Bischoff Helge,Lam Sivuonthanh,Cardona Andres,Morris Stefanie,Liu Stephen V.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference19 articles.

1. Small-cell lung cancer;Rudin;Nat Rev Dis Primers,2021

2. Update on the biology, management, and treatment of small cell lung cancer (SCLC);Saltos;Front Oncol,2020

3. Phase II study of maintenance pembrolizumab in patients with extensive-stage small cell lung cancer (SCLC);Gadgeel;J Thorac Oncol,2018

4. Nivolumab and ipilimumab as maintenance therapy in extensive-disease small-cell lung cancer: CheckMate 451;Owonikoko;J Clin Oncol,2021

5. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer;Horn;N Engl J Med,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of anlotinib plus anti-programmed cell death 1/ligand 1 (anti-PD-1/PD-L1) antibodies as maintenance therapy after first-line chemotherapy combined with anti-PD-1/PD-L1 antibodies in extensive-stage small cell lung cancer: a real-world study;Journal of Thoracic Disease;2024-07

2. Big Decisions on Small Cell Lung Cancer: A Focus on Clinical Care Updates and Patient Perspectives;American Society of Clinical Oncology Educational Book;2024-06

3. Impact of immune‐related adverse events on survival outcomes in extensive‐stage small cell lung cancer patients treated with immune checkpoint inhibitors;Cancer Medicine;2024-04

4. Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial;The Oncologist;2024-02-20

5. A retrospective analysis of prognostic factors and treatment choices in small cell lung cancer with liver metastasis;Journal of Thoracic Disease;2023-12